Top

Indian Journal of Otolaryngology and Head & Neck Surgery

Published in:

04-08-2021 | Wound Debridement | Original Article

Clinical Study of Surge of Mucormycosis in COVID-19 Pandemic: A Tertiary Care Center Study

Authors: Devang P. Gupta, Shalu Gupta, Chaitry K. Shah, S. R. Sreevidya

Published in: Indian Journal of Otolaryngology and Head & Neck Surgery | Special Issue 2/2022

Abstract

The aim of this study is to evaluate the prevalence, pathogenesis and management of mucormycosis in post covid 19 patients in our tertiary care covid dedicated hospital. A prospective cross sectional study was done in 70 patients who were admitted in the covid department of BJ Medical College, Civil hospital Ahmedabad and presented with mucormycosis during admission or after discharge over a period of 10 months from March 2020 to December 2020. Middle aged to elderly population were found to be most commonly affected with mucormycosis. It was found that majority of the affected population was uncontrolled diabeteic and had a delayed presentation to hospital due to ongoing covid pandemic crisis. Covid infection had major effect on the hormonal balance of the body as evident from the uncontrolled blood glucose levels of affected patients. In patients with mucormycosis, early detection, surgical debridement, suitable antifungal therapy, and control of risk factors like diabetes mellitus are the main parameters of successful management of this lethal infection. Early diagnosis and treatment of mucormycosis can be life saving as it is a rapidly progressing disease and have been proven fatal.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet 395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5CrossRefPubMed

World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it 2020 [31/03/2020]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it

Ceccarelli M, Berretta M, Venanzi RE, Nunnari G, Cacopardo B (2020) Differences and similarities between severe acute respiratory syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet. Eur Rev Med Pharmacol Sci 24(5):2781–2783. https://doi.org/10.26355/eurrev_202003_20551CrossRefPubMed

World Health Organization. Rolling updates on coronavirus disease (COVID-19) 2020 [31/03/2020]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.

Vijayabala GS, Annigeri RG, Sudarshan R (2013) Mucormycosis in a diabetic ketoacidosis patient. Asian Pac J Trop Biomed 3(10):830–833CrossRefPubMedPubMedCentral

Sarrami AH, Setareh M, Izadinejad M, Afshar-Moghaddam N, Baradaran-Mahdavi MM, Meidani M (2013) Fatal disseminated mucormycosis in an immunocompotent patient: a case report and literature review. Int J Prev Med 4(12):1468PubMedPubMedCentral

Herrera DA, Dublin AB, Ormsby EL, Aminpour S, Howell LP (2009) Imaging findings of rhinocerebral mucormycosis. Skull base 19(2):117CrossRefPubMedPubMedCentral

Mohammadi R, Meidani M, Mostafavizadeh K, Iraj B, Hamedani P, Sayedain SM, Mokhtari M (2015) Case series of rhinocerebral mucormycosis occurring in diabetic patients. Caspian J Intern Med 6(4):243–246PubMedPubMedCentral

Karla S, Natally H, Guerreiro Nicolau FC, de Castro I, de Giassi KS (2019) Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity. BMC Infect Dis. https://doi.org/10.1186/s12879-019-4592-0CrossRef

10.

Yang JK, Feng Y, Yuan MY, Yuan SY, Fu HJ, Wu BY (2006) Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med 23(6):623–628. https://doi.org/10.1111/j.1464-5491.2006.01861.xCrossRefPubMed

11.

Rani BG, Salem AA, Robert B, Harunor R (2016) Risk factors for severity and mortality in patients with MERS-CoV: analysis of publicly available data from Saudi Arabia. Virol Sin 31(1):81–84. https://doi.org/10.1007/s12250-015-3679-zCrossRef

12.

Aihong W, Zhao Weibo Xu, Jianwen ZG (2020) Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Res Clin Pract 162:108118. https://doi.org/10.1016/j.diabres.2020.108118CrossRef

13.

Chakrabarti A, Das A, Mandal J, Shivaprakash MR, George VK, Tarai B, Rao P et al (2006) The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol 44:335–342CrossRefPubMed

14.

Roden MM, Te Z, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL et al (2005) Epidemiology and outcome of zygomycosis:a review of 929 reported cases. Clin Infect Dis 41:634–53CrossRefPubMed

15.

Effat KG, Karam M, El-Kabani A (2005) Potts puffy tumour caused by mucormycosis. J Laryngol Otol 119:643–5CrossRefPubMed

16.

Parfery NA (1986) Improved diagonis and prognosis of mucormycosis. A clinicopathologic study of cases. Medicine (Baltimore) 65:113–23CrossRef

17.

Kim J-G, Park HJ, Park JH, Baek J, Kim HJ, Cha I-H, Nam W (2013) Importance of immediate surgical intervention and antifungal treatment for rhinocerebral mucormycosis. J Korean Assoc Oral Maxillofac Surg 39:246–250CrossRefPubMedPubMedCentral

18.

Spellberg B, Edwards J, Ibrahim A (2005) Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 18(3):556–569CrossRefPubMedPubMedCentral

19.

Hosseini S, Borghei P (2005) Rhinocerebral mucormycosis:pathways of spread. Eur Arch Otorhinolaryngol 262:932–938CrossRefPubMed

20.

Talmi Y, Goldschmied-Reouven A, Bakon M, Barshack I, Wolf M, Horowitz Z, Berkowicz M, Keller N, Kronenberg J (2002) Rhino-orbital and rhino-orbitocerebral mucormycosis. Otolaryngol Head Neck Surg 127:22–31CrossRefPubMed

21.

Thajeb P, Thajeb T, Dai D (2004) Fatal strokes in patients with rhino-orbito-cerebral mucormycosis and associated vasculopathy. Scand J Infect Dis 36:643–648CrossRefPubMed

22.

Sehgal A, Raghavendran M, Kumar D, Srivastava A, Dubey D, Kumar A (2004) Rhinocerebral mucormycosis causing basilar artery aneurysm with concomitant fungal colonic perforation in renal allograft recipient: a case report. Transplantation 78:949–950CrossRefPubMed

23.

Lass-Florl C (2009) Zygomycosis: conventional laboratory diagnosis. Clin Microbiol Infect 15(SUPPL5):60–65CrossRefPubMed

24.

Greenberg R, Scott L, Vaughn H, Ribes J (2004) Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis 17:517–525CrossRefPubMed

25.

Spellberg B, Walsh T, Kontoyiannis D, Edward JJR, Ibrahim A (2009) Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 48:1743–1751CrossRefPubMed

26.

Reed C, Bryant R, Ibrahim A, Edwards JJR, Filler S, Golderg R, Spellberg B (2008) Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis 47:364–371CrossRefPubMed

27.

Recovery Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with COVID-19—Preliminary report. N Engl J Med. 2020. Available at: https://www.ncbi.nlm.nih.gov/pubmed/32678530

28.

Sylvia K (2013) Diabetes and infection: is there a link?—A mini-review. Gerontology 59(2):99–104. https://doi.org/10.1159/000345107CrossRef

29.

Petrie JR, Guzik TJ, Touyz RM (2018) Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Canadian J Cardiol 34(5):575–584. https://doi.org/10.1016/j.cjca.2017.12.005CrossRef

30.

Balai E, Mummadi S, Jolly K, Darr A, Aldeerawi H (2020) Rhinocerebral Mucormycosis: a Ten-Year Single Centre Case Series. Cureus. https://doi.org/10.7759/cureus.11776CrossRefPubMedPubMedCentral

31.

Nezafati S, Kazemi A, Asgari K et al (2018) Rhinocerebral mucormycosis, risk factors and the type of oral manifestations in patients referred to a university hospital in Tabriz, Iran 2007–2017. Mycoses 61:764–769. https://doi.org/10.1111/myc.12802CrossRefPubMed

32.

Kolekar JS (2015) Rhinocerebral mucormycosis: a retrospective study. Indian J Otolaryngol Head Neck Surg 67:93–96. https://doi.org/10.1007/s12070-014-0804-5CrossRefPubMed

Title: Clinical Study of Surge of Mucormycosis in COVID-19 Pandemic: A Tertiary Care Center Study
Authors: Devang P. Gupta
Shalu Gupta
Chaitry K. Shah
S. R. Sreevidya
Publication date: 04-08-2021
Publisher: Springer India
Keywords: Wound Debridement
Care
COVID-19
Diabetes
Published in: Indian Journal of Otolaryngology and Head & Neck Surgery / Issue Special Issue 2/2022
Print ISSN: 2231-3796
Electronic ISSN: 0973-7707
DOI: https://doi.org/10.1007/s12070-021-02784-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Clinical Study of Surge of Mucormycosis in COVID-19 Pandemic: A Tertiary Care Center Study

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 2/2022

Rare Presentation of Nasal Mucormycosis

Tracing, Tracking and Treating COVID-19 Associated Rhino-Orbito Cerebral Mucormycosis (ROCM)

In Silico Analysis and Comparative Molecular Docking Study of FDA Approved Drugs with Transforming Growth Factor Beta Receptors in Oral Submucous Fibrosis

Role of Primary Aetiology of Intubation in Acquired Laryngotracheal Stenosis: An Institutional Audit and Review of Literature

Management of Maxillofacial Trauma in Road Traffic Accident (RTA) at Tertiary Care Center

Outcomes of Patients Undergoing Emergency Tracheostomy During COVID 19 Pandemic: Our Experience from a Tertiary Care Centre in North-East India